Evidence map›Paper›PMID 39417278›Full record

ArticleEuropean heart journal. Cardiovascular Imaging2025

Myocardial disarray and fibrosis across hypertrophic cardiomyopathy stages associate with ECG markers of arrhythmic risk.

Z Ashkir, A H A Samat, R Ariga, L E M Finnigan, S Jermy, M A Akhtar, G Sarto, P Murthy, B W Y Wong, M P Cassar and 8 more

Abstract read
In one paragraph

Article in European heart journal. Cardiovascular Imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Z AshkirOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.ORCID 0000-0002-4260-7420
A H A SamatOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.
R ArigaOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.
L E M FinniganOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.
S JermyFaculty of Health Sciences, Cape Universities Body Imaging Centre (CUBIC), University of Cape Town, South Africa.
M A AkhtarOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.
G SartoOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.
P MurthyOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.
B W Y WongOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.
M P CassarOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.
N BeyhoffOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.
E C WicksInherited Cardiac Conditions (ICC) Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
K ThomsonDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
M MahmodOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.ORCID 0000-0002-0601-3510
E M TunnicliffeOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.
S NeubauerOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.ORCID 0000-0001-9017-5645
H WatkinsDivision of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
B RamanOxford Centre for Clinical Magnetic Resonance Research (OCMR), University of Oxford, Oxford OX3 9DU, UK.ORCID 0000-0002-1239-9608

Funding

British Heart Foundation FS/CRTF/21/24144British Heart Foundation Oxford Centre of Research Excellence RE/18/3/34214Clinical Research Training FellowshipIntermediate Clinical Transitional Research FellowshipNIHR Oxford Biomedical Research Centre
6 · The paper itself

Abstract

aimsMyocardial disarray, an early feature of hypertrophic cardiomyopathy (HCM) and a substrate for ventricular arrhythmia, is poorly characterized in pre-hypertrophic sarcomeric variant carriers (SARC+LVH-). Using diffusion tensor cardiac magnetic resonance (DT-CMR) we assessed myocardial disarray and fibrosis in both SARC+LVH- and HCM patients and evaluated the relationship between microstructural alterations and electrocardiographic (ECG) parameters associated with arrhythmic risk. METHODS AND

resultsSixty-two individuals (24 SARC+LVH-, 24 HCM, and 14 matched controls) were evaluated with multi-parametric CMR including stimulated echo acquisition mode DT-CMR, and blinded quantitative 12-lead ECG analysis. Mean diastolic fractional anisotropy (FA) was reduced in HCM compared with SARC+LVH- and controls (0.49 ± 0.05 vs. 0.52 ± 0.04 vs. 0.53 ± 0.04, P = 0.009), even after adjustment for differences in extracellular volume (ECV) (P = 0.038). Both HCM and SARC+LVH- had segments with significantly reduced diastolic FA relative to controls (54 vs. 25 vs. 0%, P = 0.002). Multiple repolarization parameters were prolonged in HCM and SARC+LVH-, with corrected JT interval (JTc) being most significant (354 ± 42 vs. 356 ± 26 vs. 314 ± 26 ms, P = 0.002). Among SARC+LVH-, JTc duration correlated negatively with mean diastolic FA (r = -0.6, P = 0.002). In HCM, the JTc interval showed a stronger association with ECV (r = 0.6 P = 0.019) than with mean diastolic FA (r = -0.1 P = 0.72). JTc discriminated SARC+LVH- from controls [area under the receiver operator curve 0.88, confidence interval 0.76-1.00, P < 0.001], and in HCM correlated with the European Society of Cardiology HCM sudden cardiac death risk score (r = 0.5, P = 0.014).

conclusionLow diastolic FA, suggestive of myocardial disarray, is present in both SARC+LVH- and HCM. Low FA and raised ECV were associated with repolarization prolongation. Myocardial disarray assessment using DT-CMR and repolarization parameters such as the JTc interval demonstrate significant potential as markers of disease activity in HCM.

Indexed as

Arrhythmias, CardiacCardiomyopathy, HypertrophicElectrocardiographyMagnetic Resonance Imaging, CineAdultCase-Control StudiesFemaleFibrosisHumansMaleMiddle AgedRisk AssessmentSeverity of Illness Indexarrhythmiacardiac magnetic resonance imagingECGhypertrophic cardiomyopathyrepolarizationsarcomeresudden cardiac death

Identifiers

PMID39417278
PMCPMC11781828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.